HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lack of resistance after re-exposure of cattle cured of Onchocerca ochengi infection with oxytetracycline.

Abstract
Although vector control and ivermectin chemotherapy have led to a dramatic reduction in the incidence of river blindness (onchocerciasis), there is a consensus that additional control tools are required to sustain and extend this success. The recognition of endosymbiotic bacteria (Wolbachia) in filariae and their targeting by antibiotics constitutes the most significant and practicable opportunity for a macrofilaricidal therapy in the short-to-medium-term. Using Onchocerca ochengi in cattle, an analog of human onchocerciasis, we have previously shown that oxytetracycline is macrofilaricidal, and protective immunity exists naturally in a subset of animals termed putatively immune. Here, we report that although 24 weeks of weekly oxytetracycline treatment eliminated adult worms, cured animals remained susceptible to re-infection by natural challenge when compared with putatively immune cattle. However, their susceptibility was not significantly different from that of concurrently exposed, heavily infected animals. Thus, cattle cured by oxytetracycline are neither hypo-susceptible nor hyper-susceptible.
AuthorsCharles K Nfon, Benjamin L Makepeace, Leo M Njongmeta, Vincent N Tanya, Alexander J Trees
JournalThe American journal of tropical medicine and hygiene (Am J Trop Med Hyg) Vol. 76 Issue 1 Pg. 67-72 (Jan 2007) ISSN: 0002-9637 [Print] United States
PMID17255232 (Publication Type: Controlled Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anthelmintics
  • Arsenicals
  • Triazines
  • melarsomine
  • Oxytetracycline
Topics
  • Animals
  • Anthelmintics (therapeutic use)
  • Arsenicals (therapeutic use)
  • Cattle
  • Cattle Diseases (drug therapy)
  • Disease Susceptibility (veterinary)
  • Female
  • Onchocerciasis (drug therapy, veterinary)
  • Oxytetracycline (therapeutic use)
  • Time Factors
  • Triazines (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: